Targeting Metalloenzymes for Therapeutic Intervention

Area of Science:

• Biochemistry and Molecular Biology
• Medicinal Chemistry
• Pharmacology

Background:

• Metalloenzymes are crucial for diverse biological functions, including DNA modification and protein breakdown.
• Their involvement in disease pathogenesis makes them significant therapeutic targets.
• Developing inhibitors for metalloenzymes is a key area in drug discovery.

Purpose of the Study:

• To provide a comprehensive overview of drug discovery initiatives targeting metalloenzymes.
• To identify and map high-value metalloenzyme targets for therapeutic development.
• To discuss current strategies for developing metalloenzyme inhibitors.

Main Methods:

• Literature review of existing research on metalloenzyme inhibitors.
• Analysis of drug discovery efforts focused on metalloenzymes.
• Identification and categorization of key metalloenzyme targets in disease.

Main Results:

• Several drug discovery programs are actively pursuing metalloenzyme inhibitors.
• A landscape of high-value metalloenzyme targets has been identified.
• Various strategies are being employed to develop effective metalloenzyme-targeted drugs.

Conclusions:

• Metalloenzymes represent a promising class of targets for novel drug development.
• Continued research into metalloenzyme inhibition is essential for advancing therapeutic interventions.
• Understanding the role of metalloenzymes in disease is critical for designing effective treatments.